Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does treatment of childhood congenital adrenal hyperplasia with prednisone adversely affect final height?

Nature Clinical Practice Endocrinology & Metabolism volume 3, pages 626–627 (2007)Cite this article

boxed-textBonfig W et al. (2007) Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. J Clin Endocrinol Metab 92: 1635–1639

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Brook CG et al. (1974) Experience with long-term therapy in congenital adrenal hyperplasia. J Pediatr 85: 12–19

    Article  CAS  Google Scholar 

  2. Horrocks PM and London DR (1987) Effects of long term dexamethasone treatment in adult patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 27: 635–642

    Article  CAS  Google Scholar 

  3. Rivkees SA and Crawford JD (2000) Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 106: 767–773

    Article  CAS  Google Scholar 

  4. Devesa J et al. (1995) Regulation of hypothalamic somatostatin by glucocorticoids. J Steroid Biochem Mol Biol 53: 277–282

    Article  CAS  Google Scholar 

  5. Punthakee Z et al. (2003) Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency. J Pediatr 143: 402–405

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. R Miller is an Instructor in Pediatrics and S Radovick is a Professor of Pediatrics at Johns Hopkins University School of Medicine, Baltimore, MD, USA.,

    Ryan Miller & Sally Radovick

Authors
  1. Ryan Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sally Radovick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sally Radovick.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, R., Radovick, S. Does treatment of childhood congenital adrenal hyperplasia with prednisone adversely affect final height?. Nat Rev Endocrinol 3, 626–627 (2007). https://doi.org/10.1038/ncpendmet0583

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0583

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing